Date:January 11, 2026
Bio Usawa will participate in the 44th J.P. Morgan Healthcare Conference, taking place January 12–15, in San Francisco. The annual conference convenes global healthcare leaders, investors, and partners to engage on the future of healthcare and life sciences.
Bio Usawa is pioneering the development and manufacturing of biologics in Africa, addressing longstanding gaps in supply, infrastructure, and access across the continent and beyond.
Members of the company’s senior leadership, including CEO and President, Dr. Menghis Bairu, will be available for meetings and discussions throughout the conference.
Organizations and partners interested in learning more about Bio Usawa’s mission to strengthen biologics manufacturing and delivery in emerging markets are encouraged to connect with the team.
Schedule a meeting: [email protected]
Bio Usawa celebrates the extraordinary vision and leadership of the African Diaspora Network (ADN) and expresses deep appreciation for this year’s Afric…
March 2026In the first half of 2026, Bio Usawa will open Sub-Saharan Africa’s first GMP-compliant monoclonal antibodies manufacturing facility in Rwanda — a histo…
March 2026Bio Usawa was honored to be received by Dr. Ivan Butera, Rwanda’s Minister of State for Health, this week to share updates on the company's progress and…
March 2026